Publications by authors named "Mohammed Fk Ibrahim"
Article Synopsis
- Concerns about the interaction between tamoxifen, a breast cancer treatment, and antidepressants have led to guidelines suggesting caution with their combined use, but the clinical significance of this interaction remains uncertain.
- A systematic review analyzed 15 relevant studies involving nearly 100,000 patients to investigate if using antidepressants alongside tamoxifen affects cancer recurrence, survival rates, quality of life, and treatment adherence.
- The review concluded that there was no consistent evidence of negative impacts from the concurrent use of tamoxifen and antidepressants, indicating a need to update existing guidelines and call for more rigorous research on this topic.
Purpose: Optimal primary febrile neutropenia (FN) prophylaxis (i.e. ciprofloxacin or granulocyte-colony stimulating factors [G-CSF]) for patients receiving docetaxel-cyclophosphamide (TC) chemotherapy is unknown.
View Article and Find Full Text PDFBackground: Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 24-48 h after taxane-based chemotherapy and lasting for 5-7 days. Relatively little is known about its incidence and impact on quality of life.
Objectives: A systematic review was conducted evaluating the incidence of TAPS in breast cancer patients receiving taxane-based chemotherapy.
Background: Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 1-3 days and lasting 5-7 days after taxane-based chemotherapy. Despite negatively impacting patient's quality of life, little is known about the optimal TAPS management. A systematic review of treatment strategies for TAPS across all tumor sites was performed.
View Article and Find Full Text PDF